BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38198744)

  • 41. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
    Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
    Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity of Candida albicans from patients with chronic oral candidiasis.
    Holbrook WP; Kippax R
    Postgrad Med J; 1979 Sep; 55(647):692-4. PubMed ID: 392486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial, antibiofilm and cytotoxic effects of a colloidal nanocarrier composed by chitosan-coated iron oxide nanoparticles loaded with chlorhexidine.
    Araujo HC; da Silva ACG; Paião LI; Magario MKW; Frasnelli SCT; Oliveira SHP; Pessan JP; Monteiro DR
    J Dent; 2020 Oct; 101():103453. PubMed ID: 32827599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative evaluation of the antifungal efficacy of sodium hypochlorite, chlorhexidine, and silver nanoparticles against Candida albicans.
    Oncu A; Celikten B; Aydın B; Amasya G; Açık L; Sevimay FS
    Microsc Res Tech; 2022 Dec; 85(12):3755-3760. PubMed ID: 36259632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nystatin effect on chlorhexidine efficacy against Streptococcus mutans as planktonic cells and mixed biofilm with Candida albicans.
    Baldino MEL; Medina-Silva R; Sumienski J; Figueiredo MA; Salum FG; Cherubini K
    Clin Oral Investig; 2022 Jan; 26(1):633-642. PubMed ID: 34160701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.
    El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
    BMC Infect Dis; 2019 Jan; 19(1):54. PubMed ID: 30651066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Brief Exposure to Drugs with Antifungal Properties on the Susceptibility of Oral Candida dubliniensis Isolates to Lysozyme and Lactoferrin.
    Ellepola ANB; Dassanayake RS; Khan Z
    Med Princ Pract; 2018; 27(6):523-530. PubMed ID: 30173211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
    de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
    J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determining the minimum inhibitory concentration of Tetraclean against Candida albicans.
    Qyasian A; Mohammadi Z; Giardino L; Palazzi F; Shalavi S; Sabbaghi S; Khoshbin E
    Niger J Med; 2014; 23(3):201-6. PubMed ID: 25185376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A promising synthetic citric crosslinked β-cyclodextrin derivative for antifungal drugs: Solubilization, cytotoxicity, and antifungal activity.
    Soe HMSH; Junthip J; Chamni S; Chansriniyom C; Limpikirati P; Thanusuwannasak T; Asasutjarit R; Pruksakorn P; Autthateinchai R; Wet-Osot S; Loftsson T; Jansook P
    Int J Pharm; 2023 Oct; 645():123394. PubMed ID: 37689255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro antifungal properties of mouthrinses containing antimicrobial agents.
    Giuliana G; Pizzo G; Milici ME; Musotto GC; Giangreco R
    J Periodontol; 1997 Aug; 68(8):729-33. PubMed ID: 9287062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal activity of alpha-mangostin against Candida albicans.
    Kaomongkolgit R; Jamdee K; Chaisomboon N
    J Oral Sci; 2009 Sep; 51(3):401-6. PubMed ID: 19776506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-biofilm properties of eucalyptol in combination with antifungals against Candida albicans isolates in patients with hematological malignancy.
    Keymaram M; Falahati M; Farahyar S; Lotfali E; Abolghasemi S; Mahmoudi S; Sadeghi F; Khalandi H; Ghasemi R; Shamsaei S; Raiesi O
    Arch Microbiol; 2022 May; 204(6):295. PubMed ID: 35508567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifungal Activity of Ethanol-extracted
    Poma-Castillo L; Espinoza-Poma M; Mauricio F; Mauricio-Vilchez C; Alvítez-Temoche D; Mayta-Tovalino F
    J Contemp Dent Pract; 2019 Oct; 20(10):1159-1163. PubMed ID: 31883250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal activity of the plant Dodonaea viscosa var. angustifolia on Candida albicans from HIV-infected patients.
    Patel M; Coogan MM
    J Ethnopharmacol; 2008 Jun; 118(1):173-6. PubMed ID: 18448291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity--drug supersaturation, toxicity on TR146 cells and release from a delivery system.
    Jacobsen J; Bjerregaard S; Pedersen M
    Eur J Pharm Biopharm; 1999 Nov; 48(3):217-24. PubMed ID: 10612032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a microtiter plate assay to detect the rate of killing of adherent Candida albicans by antifungal agents.
    Hamers AD; Shay K; Hahn BL; Sohnle PG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):44-9. PubMed ID: 8850482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
    Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
    Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.